Global Next Generation Sequencing Services Market Size Study, By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing), By Application, By End User and Regional Forecast, 2017-2025

  • Product Code:
    RP-ID-10012986
  • Published Date:
    21 Oct 2022
  • Region:
    Global
  • Pages:
    180
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

Global Next Generation Sequencing market is valued approximately USD 3.5 billion in 2016. The market growth is majorly attributed to the factors such as growing applications of next generation sequencing and rising technological innovations in sequencing platforms. Further increasing demand for drug discovery and rising research spending are other prominent factors fuelling the growth in the market. However, data storage and analysis are still a major concern before handling the complex sequencing data.
Applications:
 Diagnostics
 Drug Discovery
 Biomarker Discovery
 Personalized Medicine
 Agriculture and Animal Research
 Other Applications

Technology:
 Sequencing by Synthesis (SBS)
 Ion Semiconductor Sequencing
 Sequencing by Ligation (SBL)
 Pyrosequencing
 Single-Molecule Real-Time Sequencing (SMRT)
 Other Technologies

End User:
 Research Centers and Academic & Government Institutes
 Hospitals & Clinics
 Pharmaceutical & Biotechnology Companies
 Other End Users

Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
o France
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Among various NGS technologies discussed in the report, the SBS technology accounted for the largest revenue share of the market in 2016. Development of advanced NGS platforms and the increasing demand for Illumina's systems are the primary growth attributes for the development of SBS technology. Further, on the basis of applications, the market is dominated by diagnostic applications with highest revenue share in 2016. Companies are constantly focusing on the development of NGS based diagnostic tests. In July 2017, FDA has approved first NGS-based diagnostic test to Thermo Fisher Scientific. This is likely to spur the companies test procedures over the forecasts period.

Geographically, the market is dominated by North America. The growth in the region is majorly driven by the rising number of collaboration among research institutions. Moreover, increasing focus of research institutes towards drug discovery is another key driving factor. Furthermore, Asia Pacific region is anticipated to grow with an eye popping CAGR over the forecasted period 2017-2025. The growth in the region is majorly driven by increasing and developing healthcare infrastructure in the region along with the rise in GPD contribution on healthcare sector.

Some of the key market players are Life Sciences Corporation (Roche Holding), Agilent Technologies, Inc., Beijing Genomics Institute, GE Healthcare, Illumina Inc., Newgene Ltd., Novartis, OXFORD GENE TECHNOLOGY, OXFORD NANOPORE TECHNOLOGIES, Pacific Biosciences of California Inc., and Siemens. Acquisitions, mergers, product development, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market.


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Eurofins Scientific F. Hoffmann-La Roche AG GATC Biotech Ag Illumina Incorporated Macrogen, Inc. Oxford Nanopore Technologies Ltd. Pacific Biosciences of California, Inc. Perkin Elmer, Inc. Qiagen NV Thermo Fischer Scientific Inc.
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->